SK129896A3 - Intranasal antimigraine composition - Google Patents
Intranasal antimigraine composition Download PDFInfo
- Publication number
- SK129896A3 SK129896A3 SK1298-96A SK129896A SK129896A3 SK 129896 A3 SK129896 A3 SK 129896A3 SK 129896 A SK129896 A SK 129896A SK 129896 A3 SK129896 A3 SK 129896A3
- Authority
- SK
- Slovakia
- Prior art keywords
- composition
- chitosan
- compound
- pharmaceutically acceptable
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94200998 | 1994-04-13 | ||
PCT/EP1995/001302 WO1995028158A1 (en) | 1994-04-13 | 1995-04-10 | Intranasal antimigraine composition |
Publications (1)
Publication Number | Publication Date |
---|---|
SK129896A3 true SK129896A3 (en) | 1997-05-07 |
Family
ID=8216793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1298-96A SK129896A3 (en) | 1994-04-13 | 1995-04-10 | Intranasal antimigraine composition |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0755253B1 (hu) |
JP (1) | JP2921988B2 (hu) |
KR (1) | KR100219952B1 (hu) |
CN (1) | CN1146151A (hu) |
AT (1) | ATE194915T1 (hu) |
AU (1) | AU684360B2 (hu) |
BG (1) | BG62197B1 (hu) |
BR (1) | BR9507369A (hu) |
CA (1) | CA2184822C (hu) |
CZ (1) | CZ286610B6 (hu) |
DE (1) | DE69518149T2 (hu) |
FI (1) | FI118295B (hu) |
HR (1) | HRP950149A2 (hu) |
HU (1) | HU219495B (hu) |
IL (1) | IL113341A (hu) |
NO (1) | NO310276B1 (hu) |
NZ (1) | NZ284454A (hu) |
PL (1) | PL179761B1 (hu) |
RO (1) | RO115414B1 (hu) |
SI (1) | SI9500121A (hu) |
SK (1) | SK129896A3 (hu) |
WO (1) | WO1995028158A1 (hu) |
ZA (1) | ZA953038B (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970032844A (ko) * | 1995-12-29 | 1997-07-22 | 김준웅 | 지속성 경비투여제제 |
UA72189C2 (uk) * | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
GB2378383A (en) * | 2001-06-06 | 2003-02-12 | Gursharan Moonga | Nasal delivery of pharmaceutical compositions in powder form |
GB0328186D0 (en) | 2003-12-05 | 2004-01-07 | West Pharm Serv Drug Res Ltd | Intranasal compositions |
US7968122B2 (en) | 2003-12-10 | 2011-06-28 | Adventrx Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
GB8904370D0 (en) * | 1989-02-25 | 1989-04-12 | Cosmas Damian Ltd | Liquid delivery compositions |
SI9300097B (en) * | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
JPH0656675A (ja) * | 1992-08-07 | 1994-03-01 | Nippon Soda Co Ltd | 家畜の乳房炎予防剤 |
-
1995
- 1995-03-27 HR HR94200998.6A patent/HRP950149A2/hr not_active Application Discontinuation
- 1995-04-10 JP JP7526682A patent/JP2921988B2/ja not_active Expired - Lifetime
- 1995-04-10 PL PL95316756A patent/PL179761B1/pl unknown
- 1995-04-10 HU HU9602806A patent/HU219495B/hu unknown
- 1995-04-10 AT AT95916618T patent/ATE194915T1/de active
- 1995-04-10 WO PCT/EP1995/001302 patent/WO1995028158A1/en active IP Right Grant
- 1995-04-10 RO RO96-01974A patent/RO115414B1/ro unknown
- 1995-04-10 AU AU23054/95A patent/AU684360B2/en not_active Expired
- 1995-04-10 DE DE69518149T patent/DE69518149T2/de not_active Expired - Lifetime
- 1995-04-10 EP EP95916618A patent/EP0755253B1/en not_active Expired - Lifetime
- 1995-04-10 CZ CZ19962920A patent/CZ286610B6/cs not_active IP Right Cessation
- 1995-04-10 CA CA002184822A patent/CA2184822C/en not_active Expired - Lifetime
- 1995-04-10 BR BR9507369A patent/BR9507369A/pt not_active Application Discontinuation
- 1995-04-10 SK SK1298-96A patent/SK129896A3/sk unknown
- 1995-04-10 KR KR1019960705599A patent/KR100219952B1/ko not_active IP Right Cessation
- 1995-04-10 NZ NZ284454A patent/NZ284454A/en not_active IP Right Cessation
- 1995-04-10 CN CN95192535A patent/CN1146151A/zh active Pending
- 1995-04-12 ZA ZA953038A patent/ZA953038B/xx unknown
- 1995-04-12 SI SI9500121A patent/SI9500121A/sl unknown
- 1995-04-12 IL IL11334195A patent/IL113341A/xx not_active IP Right Cessation
-
1996
- 1996-10-08 BG BG100889A patent/BG62197B1/bg unknown
- 1996-10-11 FI FI964095A patent/FI118295B/fi not_active IP Right Cessation
- 1996-10-11 NO NO19964333A patent/NO310276B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6677346B1 (en) | Methods comprising intranasal morphine | |
US6225343B1 (en) | Compositions and methods comprising morphine gluconate | |
US8772309B2 (en) | Pharmaceutical formulation of apomorphine for buccal administration | |
JP2003501468A (ja) | アポモルヒネの経鼻送達 | |
SK283301B6 (sk) | Použitie farmaceutickej zmesi na ústne podanie | |
JPH06504991A (ja) | 組成物 | |
JPH05262651A (ja) | 向精神薬の安定化溶液 | |
CN103747786A (zh) | 比马前列素和溴莫尼定的固定剂量组合 | |
MX2012008516A (es) | Agonista alfa-2 adrenergico que tiene larga duracion de efecto de baja presion intraocular. | |
SK129896A3 (en) | Intranasal antimigraine composition | |
US7576133B2 (en) | Methods and compositions for nasal administration of modafinil | |
US6054462A (en) | Intranasal antimigraine compositions | |
TW200808373A (en) | Liquid drug formulation | |
EP1297838B1 (en) | Pralmorelin-containing nasal drop preparations | |
US6723732B1 (en) | Percutaneously adminstrable preparations containing cerebral function activators | |
CN1726915B (zh) | 盐酸纳洛酮鼻腔给药系统或组合物及其制备方法 | |
EP0842658B1 (en) | Photostable aqueous solution containing benzyl alcohol derivatives | |
EP0296227A1 (en) | Nasal delivery of amino acids | |
CZ247299A3 (cs) | Použití farmaceutické směsi pro ústní podání |